Clinical Trials Browser

Completed × MK 2206 × Tumor-Agnostic × Clear all

NCT00848718 2019-11-12

MK-2206-003

Phase 1 Completed

77 enrolled 24 charts

Neoplasms

NCT00670488 2019-04-01

MK-2206-002

Phase 1 Completed

104 enrolled 28 charts

Neoplasms

NCT01235897 2014-04-17

MK-2206, Paclitaxel and Trastuzumab in Treating Patients With HER2-overexpressing Solid Tumor Malignancies

Phase 1 Completed

17 enrolled 7 charts

Neoplasms